NCT06097585View on ClinicalTrials.gov

Gliflozins on HF in Regurgitant Rheumatic Heart

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

April 1, 2025

Conditions

Rheumatic Heart DiseaseHeart Failure

Interventions

DRUG

SGLT2 inhibitor

case control study in which group will receive SGLT2I and group will not , to detect impact of the drug in changing NYHA class for heart failure and echographic parameter

All Listed Sponsors

lead

Assiut University

OTHER

NCT06097585 - Gliflozins on HF in Regurgitant Rheumatic Heart | Biotech Hunter | Biotech Hunter